EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Dual-time-point 68Ga-FAPI PET/CT in gastrointestinal malignancies: head-to-head comparison with 18 F-FDG for lesion detection and patient-level assessment

Hasan Pala, Murat Tuncel, Suayib Yalcin, Erdem Karabulut, Nezih Akkapulu, Timucin Erol, Omer Ugur

Annals of Nuclear Medicine · 2026

DOI: 10.1007/s12149-026-02249-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annals of Nuclear Medicine, 2026. Verfasst von Hasan Pala und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye. hasanpala97@gmail.com. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Gastrointestinal Neoplasms. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare the diagnostic performance of 18 F-Fluorodeoxyglucose (FDG) and 68Ga-fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) in gastrointestinal malignancies, with particular emphasis on lesion detection, peritoneal disease assessment, and the potential added value of dual-time-point FAPI imaging.

Methods

Thirty-eight patients with histologically confirmed gastrointestinal cancers who underwent both FDG and FAPI PET/CT within a 4-week interval were retrospectively analyzed. FAPI PET/CT images were acquired at 10 and 60 min after tracer injection. Patient-level analyses (staging/restaging accuracy, impact on management) and lesion-based analyses (detection rate, characterization, maximum standardized uptake value [SUVmax] dynamics, lesion size) were evaluated against follow-up data as the reference standard.

Results

FAPI PET/CT demonstrated superior agreement with the reference standard compared with FDG PET/CT for staging and restaging (κ = 0.91 vs. 0.32). On lesion-based analysis, FAPI showed markedly higher detection rate for malignant lesions (86% vs. 34%) and fewer indeterminate findings. Median peritoneal carcinomatosis index score and the number of detected malignant lesions per patient were significantly higher with FAPI PET/CT ( p < 0.001). Dual-time-point FAPI imaging revealed a significant increase in SUVmax from early to later time points in malignant lesions, whereas benign lesions showed no significant change. Larger lesions (> 10 mm) demonstrated more pronounced delayed uptake, and greater early-to-delayed SUVmax increases were independently associated with malignancy, suggesting a potential role for dynamic uptake patterns in lesion characterization.

Conclusions

Dual-time-point 68Ga-FAPI PET/CT demonstrated superior lesion detectability compared with FDG PET/CT in gastrointestinal malignancies and may help reduce diagnostic uncertainty. These findings suggest that dual-time-point FAPI imaging may provide incremental value for lesion characterization and support its complementary role in oncologic imaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Gastrointestinal NeoplasmsHumansFemaleMaleMiddle AgedAgedRetrospective StudiesTime FactorsFibroblast Activation Protein AlphaGallium RadioisotopesAdultAged, 80 and overEndopeptidasesQuinolines

Stichwörter der Autor:innen

18F-FDG PET/CTDual-phase FAPI imagingGastrointestinal MalignanciesLesion DetectionPatient-Level AssessmentPeritoneal Carcinomatosis

Substanzen

Fluorodeoxyglucose F1868Ga-FAPIFibroblast Activation Protein AlphaGallium RadioisotopesEndopeptidasesQuinolines

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Türkiye. hasanpala97@gmail.com.
  • Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye. hasanpala97@gmail.com.
  • Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Department of Medical Oncology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Department of Biostatistics, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
  • Department of General Surgery, Hacettepe University Faculty of Medicine, Ankara, Türkiye.

Förderung

  • Hacettepe University

Zitieren

APA

Pala, H., Tuncel, M., Yalcin, S., Karabulut, E., Akkapulu, N., Erol, T., & Ugur, O. (2026). Dual-time-point 68Ga-FAPI PET/CT in gastrointestinal malignancies: head-to-head comparison with 18 F-FDG for lesion detection and patient-level assessment. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-026-02249-2

Vancouver

Pala H, Tuncel M, Yalcin S, Karabulut E, Akkapulu N, Erol T, et al. Dual-time-point 68Ga-FAPI PET/CT in gastrointestinal malignancies: head-to-head comparison with 18 F-FDG for lesion detection and patient-level assessment. Annals of Nuclear Medicine. 2026. doi:10.1007/s12149-026-02249-2

BibTeX
@article{Pala2026,
  author = {Pala, Hasan and Tuncel, Murat and Yalcin, Suayib and Karabulut, Erdem and Akkapulu, Nezih and Erol, Timucin and Ugur, Omer},
  title = {Dual-time-point 68Ga-FAPI PET/CT in gastrointestinal malignancies: head-to-head comparison with 18 F-FDG for lesion detection and patient-level assessment},
  journal = {Annals of Nuclear Medicine},
  year = {2026},
  doi = {10.1007/s12149-026-02249-2}
}
Kostenlos starten →